Kimberly McBennett, MD, PhD
Internal Medicine, Pediatric Pulmonology
Accepting New Patients
Schedule an Appointment
- Director, Adult Cystic Fibrosis Clinical Care Center, UH Rainbow Babies and Children's Hospital
- Director, Adult Cystic Fibrosis Program, UH Cleveland Medical Center
- Co-Director, Adult Cystic Fibrosis Therapeutics Development Center, UH Rainbow Babies and Children's Hospital
- Director, Cystic Fibrosis Center, UH Cleveland Medical Center
- Assistant Professor, CWRU School of Medicine
- Associate Professor, CWRU School of Medicine
Kimberly McBennet, MD, PhD is a specialist and clinical educator in pediatric pulmonary (lung) disease in the Division of Pediatric Pulmonology, Allergy, Immunology and Sleep Medicine at University Hospitals Rainbow Babies & Children’s Hospital since 2014. She sees patients at UH Rainbow Babies & Children’s main campus in Cleveland, OH.
Dr. McBennet trains fellows in the adult Cystic Fibrosis rotation and is a lecturer in the fellowship's core lecture series.
Dr. McBennet is board certified in hospice and palliative medicine and internal medicine. Her academic interests include adult Cystic Fibrosis, palliative care, and nutrition. Her research focuses on the use of MRI to detect early systemic disease in Cystic Fibrosis patients, Cystic Fibrosis quality improvement and is involved in Cystic Fibrosis clinical trials.
- Cystic Fibrosis
- Internal Medicine
- Hospice and Palliative Medicine - American Board of Internal Medicine
- Internal Medicine - American Board of Internal Medicine
Residency | Internal Medicine
Internal Medicine - Akron City Hospital (Summa Health System) (2004 - 2005)
Residency | Internal Medicine/Pediatrics
Internal Medicine/Pediatrics - Akron Children's Hospital (2001 - 2004)
Northeast Ohio Medical University (NEOMED) (2001)
Kent State University (1999)
University Of Pittsburgh At Johnstown (1993)
University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.
UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.
View UH’s policy (PDF) on practitioner-industry relationships.
As of December 31, 2016, Kimberly McBennett did not disclose any Outside Relationships with Industry.